These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 29921511)

  • 1. The lncRNA SNHG3 regulates energy metabolism of ovarian cancer by an analysis of mitochondrial proteomes.
    Li N; Zhan X; Zhan X
    Gynecol Oncol; 2018 Aug; 150(2):343-354. PubMed ID: 29921511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative proteomics revealed energy metabolism pathway alterations in human epithelial ovarian carcinoma and their regulation by the antiparasite drug ivermectin: data interpretation in the context of 3P medicine.
    Li N; Li H; Wang Y; Cao L; Zhan X
    EPMA J; 2020 Dec; 11(4):661-694. PubMed ID: 33240452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of the mitochondrial proteome in human ovarian carcinomas.
    Li N; Li H; Cao L; Zhan X
    Endocr Relat Cancer; 2018 Oct; 25(10):909-931. PubMed ID: 29997262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of Mitochondria from Ovarian Cancer Tissues and Control Ovarian Tissues for Quantitative Proteomics Analysis.
    Zhan X; Li H; Qian S; Zhan X; Li N
    J Vis Exp; 2019 Nov; (153):. PubMed ID: 31789316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of SNHG3 expression associated with poor prognosis and enhances malignant progression of ovarian cancer.
    Hong L; Chen W; Wu D; Wang Y
    Cancer Biomark; 2018; 22(3):367-374. PubMed ID: 29758922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNAs expression profiling in normal ovary, benign ovarian cyst and malignant epithelial ovarian cancer.
    Wang H; Fu Z; Dai C; Cao J; Liu X; Xu J; Lv M; Gu Y; Zhang J; Hua X; Jia G; Xu S; Jia X; Xu P
    Sci Rep; 2016 Dec; 6():38983. PubMed ID: 27941916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyruvate uptake is increased in highly invasive ovarian cancer cells under anoikis conditions for anaplerosis, mitochondrial function, and migration.
    Caneba CA; Bellance N; Yang L; Pabst L; Nagrath D
    Am J Physiol Endocrinol Metab; 2012 Oct; 303(8):E1036-52. PubMed ID: 22895781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic analysis reveals a lncRNA-mRNA co-expression network associated with platinum resistance in high-grade serous ovarian cancer.
    Fang L; Wang H; Li P
    Invest New Drugs; 2018 Apr; 36(2):187-194. PubMed ID: 29082457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells.
    Zheng X; Zhou Y; Chen W; Chen L; Lu J; He F; Li X; Zhao L
    Cell Physiol Biochem; 2018; 51(3):1340-1353. PubMed ID: 30481782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncSOX4 serves an oncogenic role in the tumorigenesis of epithelial ovarian cancer by promoting cell proliferation and inhibiting apoptosis.
    Liu Y; Wang Y; Yao D; Cui D
    Mol Med Rep; 2018 Jun; 17(6):8282-8288. PubMed ID: 29693704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lowly-expressed lncRNA GAS5 facilitates progression of ovarian cancer through targeting miR-196-5p and thereby regulating HOXA5.
    Zhao H; Yu H; Zheng J; Ning N; Tang F; Yang Y; Wang Y
    Gynecol Oncol; 2018 Nov; 151(2):345-355. PubMed ID: 30201235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of the Long Noncoding RNA SNHG3 Promotes Lung Adenocarcinoma Proliferation.
    Liu L; Ni J; He X
    Dis Markers; 2018; 2018():5736716. PubMed ID: 30154938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA-HOST2 regulates cell biological behaviors in epithelial ovarian cancer through a mechanism involving microRNA let-7b.
    Gao Y; Meng H; Liu S; Hu J; Zhang Y; Jiao T; Liu Y; Ou J; Wang D; Yao L; Liu S; Hui N
    Hum Mol Genet; 2015 Feb; 24(3):841-52. PubMed ID: 25292198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and validation of differentially expressed proteins in epithelial ovarian cancers using quantitative proteomics.
    Qu H; Chen Y; Cao G; Liu C; Xu J; Deng H; Zhang Z
    Oncotarget; 2016 Dec; 7(50):83187-83199. PubMed ID: 27825122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SNHG3 correlates with malignant status and poor prognosis in hepatocellular carcinoma.
    Zhang T; Cao C; Wu D; Liu L
    Tumour Biol; 2016 Feb; 37(2):2379-85. PubMed ID: 26373735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation.
    Pastò A; Bellio C; Pilotto G; Ciminale V; Silic-Benussi M; Guzzo G; Rasola A; Frasson C; Nardo G; Zulato E; Nicoletto MO; Manicone M; Indraccolo S; Amadori A
    Oncotarget; 2014 Jun; 5(12):4305-19. PubMed ID: 24946808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent organo-osmium compound shifts metabolism in epithelial ovarian cancer cells.
    Hearn JM; Romero-Canelón I; Munro AF; Fu Y; Pizarro AM; Garnett MJ; McDermott U; Carragher NO; Sadler PJ
    Proc Natl Acad Sci U S A; 2015 Jul; 112(29):E3800-5. PubMed ID: 26162681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microarray analysis reveals differentially expressed lncRNAs in benign epithelial ovarian cysts and normal ovaries.
    Liu X; Dai C; Jia G; Xu S; Fu Z; Xu J; Li Q; Ruan H; Xu P
    Oncol Rep; 2017 Aug; 38(2):799-808. PubMed ID: 28656240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA MALAT1 promotes proliferation and metastasis in epithelial ovarian cancer via the PI3K-AKT pathway.
    Jin Y; Feng SJ; Qiu S; Shao N; Zheng JH
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3176-3184. PubMed ID: 28770968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial pyruvate carrier function determines cell stemness and metabolic reprogramming in cancer cells.
    Li X; Han G; Li X; Kan Q; Fan Z; Li Y; Ji Y; Zhao J; Zhang M; Grigalavicius M; Berge V; Goscinski MA; Nesland JM; Suo Z
    Oncotarget; 2017 Jul; 8(28):46363-46380. PubMed ID: 28624784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.